Christiana Stamoulis

Ms. Stamoulis is a senior executive in the biopharmaceutical industry, with extensive experience in developing strategies for sustainable growth, and expertise in the execution of complex M&A deals, strategic collaborations and capital raising transactions. She brings nearly 20 years of experience in the life sciences industry, as a strategic and corporate finance advisor to CEOs and Boards of Directors of global biopharmaceutical companies, a senior executive and a director of a public company board. Ms. Stamoulis currently serves as a director of the Board of Hologic, a leading global developer and supplier of diagnostic products, medical imaging systems, and surgical products and is a member of the Audit and the Corporate Development Committees. Until recently, Ms. Stamoulis was the Senior Vice President and Head of Corporate Strategy and Business Development at Vertex and a member of Vertex’s Executive Team. She helped develop Vertex’s corporate vision of the future and led the development of strategies and initiatives to achieve this vision. She also led the identification, evaluation and execution of key business collaborations to enable Vertex to achieve its strategic objectives and position the company for sustainable long-term growth. Prior to joining Vertex, she spent nearly 15 years in the investment banking and management consulting industries. She was a Managing Director at Citigroup’s Investment Banking division and led the building of the firm’s Life Sciences group. Prior to Citigroup, she was in the Healthcare Investment Banking Group at Goldman Sachs, where she spent the majority of her investment banking career. As an investment banker, she has advised clients and has led the execution of M&A and capital raising deals with aggregate value in excess of $100 billion. Ms Stamoulis started her professional career as a strategy consultant at The Boston Consulting Group where she advised clients on major strategy and organizational change initiatives